-
Je něco špatně v tomto záznamu ?
Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity
DE. Arking, G. Atzmon, A. Arking, N. Barzilai, HC. Dietz,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, Research Support, U.S. Gov't, P.H.S.
Grantová podpora
DK 20541
NIDDK NIH HHS - United States
M01-RR12248
NCRR NIH HHS - United States
MH070172
NIMH NIH HHS - United States
P01 AG-03949-01A1
NIA NIH HHS - United States
R01 AG-18728-01A1
NIA NIH HHS - United States
NLK
Free Medical Journals
od 1953 do Před 1 rokem
Freely Accessible Science Journals
od 1953 do Před 1 rokem
Journals@Ovid Ovid Full Text
od 2000-01-01 do 2010-02-01
Open Access Digital Library
od 1953-01-01
Open Access Digital Library
od 1953-01-01
- MeSH
- alely MeSH
- analýza přežití MeSH
- cévní mozková příhoda genetika MeSH
- dlouhověkost genetika MeSH
- genetická predispozice k nemoci MeSH
- genetická variace MeSH
- genotyp MeSH
- HDL-cholesterol krev MeSH
- kardiovaskulární nemoci epidemiologie MeSH
- krevní tlak genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- missense mutace MeSH
- modely genetické MeSH
- multivariační analýza MeSH
- odds ratio MeSH
- proporcionální rizikové modely MeSH
- prospektivní studie MeSH
- průřezové studie MeSH
- rizikové faktory MeSH
- selekce (genetika) MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- substituce aminokyselin MeSH
- židé genetika MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
- Geografické názvy
- Česká republika MeSH
- východní Evropa MeSH
We previously identified a functional variant of KLOTHO, termed KL-VS, that is associated with human aging and early-onset occult coronary artery disease. Here, we determine whether the KL-VS allele influences cardiovascular disease risk factors, cardiovascular events, and ultimately, mortality. A total of 525 Ashkenazi Jews composed of 216 probands (age > or =95 years) and 309 unrelated individuals (ages 51 to 94) were genotyped for the KL-VS allele. In concordance with our previous data in Czech individuals (age > or =79; P<0.01), a heterozygous advantage for longevity was observed for individuals > or =79 years of age (P<0.004). Combined analysis indicates a 1.57-fold (95% CI, 1.23 to 1.98) increased odds ratio (OR) for 5-year survival in two independent populations (P<0.0002). Cardiovascular disease risk factors were assessed through multivariate regression analysis, demonstrating that high-density lipoprotein cholesterol (HDL-C; P<0.05) and systolic blood pressure (SBP; P<0.008) are associated with KL-VS genotype. History of vascular events was analyzed using logistic regression, indicating that after adjustment for traditional risk factors, heterozygous individuals were at significantly lower risk for stroke than wild-type individuals (OR, 5.88; 95% CI, 1.18 to 29.41), whereas homozygous KL-VS individuals had the highest risk (OR, 30.65; 95% CI, 2.55 to 368.00). Similarly, prospective analysis of mortality in probands using Cox regression indicates that wild-type individuals have a 2.15-fold (95% CI, 1.18 to 3.91) and homozygous KL-VS individuals a 4.49-fold (95% CI, 1.35 to 14.97) increase in relative risk for mortality after adjusting for potential confounders. Thus, cross-sectional and prospective studies confirm a genetic model in which the KL-VS allele confers a heterozygous advantage in conjunction with a marked homozygous disadvantage for HDL-C levels, SBP, stroke, and longevity.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20013827
- 003
- CZ-PrNML
- 005
- 20200915104408.0
- 007
- ta
- 008
- 200911s2005 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1161/01.RES.0000157171.04054.30 $2 doi
- 035 __
- $a (PubMed)15677572
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Arking, Dan E $u McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Md 21205, USA.
- 245 10
- $a Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity / $c DE. Arking, G. Atzmon, A. Arking, N. Barzilai, HC. Dietz,
- 520 9_
- $a We previously identified a functional variant of KLOTHO, termed KL-VS, that is associated with human aging and early-onset occult coronary artery disease. Here, we determine whether the KL-VS allele influences cardiovascular disease risk factors, cardiovascular events, and ultimately, mortality. A total of 525 Ashkenazi Jews composed of 216 probands (age > or =95 years) and 309 unrelated individuals (ages 51 to 94) were genotyped for the KL-VS allele. In concordance with our previous data in Czech individuals (age > or =79; P<0.01), a heterozygous advantage for longevity was observed for individuals > or =79 years of age (P<0.004). Combined analysis indicates a 1.57-fold (95% CI, 1.23 to 1.98) increased odds ratio (OR) for 5-year survival in two independent populations (P<0.0002). Cardiovascular disease risk factors were assessed through multivariate regression analysis, demonstrating that high-density lipoprotein cholesterol (HDL-C; P<0.05) and systolic blood pressure (SBP; P<0.008) are associated with KL-VS genotype. History of vascular events was analyzed using logistic regression, indicating that after adjustment for traditional risk factors, heterozygous individuals were at significantly lower risk for stroke than wild-type individuals (OR, 5.88; 95% CI, 1.18 to 29.41), whereas homozygous KL-VS individuals had the highest risk (OR, 30.65; 95% CI, 2.55 to 368.00). Similarly, prospective analysis of mortality in probands using Cox regression indicates that wild-type individuals have a 2.15-fold (95% CI, 1.18 to 3.91) and homozygous KL-VS individuals a 4.49-fold (95% CI, 1.35 to 14.97) increase in relative risk for mortality after adjusting for potential confounders. Thus, cross-sectional and prospective studies confirm a genetic model in which the KL-VS allele confers a heterozygous advantage in conjunction with a marked homozygous disadvantage for HDL-C levels, SBP, stroke, and longevity.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a substituce aminokyselin $7 D019943
- 650 _2
- $a krevní tlak $x genetika $7 D001794
- 650 _2
- $a kardiovaskulární nemoci $x epidemiologie $7 D002318
- 650 _2
- $a HDL-cholesterol $x krev $7 D008076
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a genetická variace $7 D014644
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a židé $x genetika $7 D007585
- 650 _2
- $a dlouhověkost $x genetika $7 D008136
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a modely genetické $7 D008957
- 650 _2
- $a multivariační analýza $7 D015999
- 650 _2
- $a missense mutace $7 D020125
- 650 _2
- $a odds ratio $7 D016017
- 650 _2
- $a proporcionální rizikové modely $7 D016016
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a selekce (genetika) $7 D012641
- 650 _2
- $a cévní mozková příhoda $x genetika $7 D020521
- 650 _2
- $a analýza přežití $7 D016019
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 651 _2
- $a východní Evropa $x etnologie $7 D005061
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, U.S. Gov't, P.H.S. $7 D013487
- 700 1_
- $a Atzmon, Gil
- 700 1_
- $a Arking, Albert
- 700 1_
- $a Barzilai, Nir
- 700 1_
- $a Dietz, Harry C
- 773 0_
- $w MED00001092 $t Circulation research $x 1524-4571 $g Roč. 96, č. 4 (2005), s. 412-418
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/15677572 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200911 $b ABA008
- 991 __
- $a 20200915104404 $b ABA008
- 999 __
- $a ok $b bmc $g 1563273 $s 1103984
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2005 $b 96 $c 4 $d 412-418 $e 20050127 $i 1524-4571 $m Circulation research $n Circ Res $x MED00001092
- GRA __
- $a DK 20541 $p NIDDK NIH HHS $2 United States
- GRA __
- $a M01-RR12248 $p NCRR NIH HHS $2 United States
- GRA __
- $a MH070172 $p NIMH NIH HHS $2 United States
- GRA __
- $a P01 AG-03949-01A1 $p NIA NIH HHS $2 United States
- GRA __
- $a R01 AG-18728-01A1 $p NIA NIH HHS $2 United States
- LZP __
- $a Pubmed-20200911